Exogenous IL-10 was shown to reverse CCl4-induced hepatic fibrosis by reducing the production of TGF-β1, MMP-2, and TIMP-1 in a rat model, demonstrating that IL-10 has antifibrotic effects via inhibiting HSC activity [73,74]. The gene discussed is TIMP1; the disease is Hepatic fibrosis.